The proportion of CD4+/CD3+/CD25+/FoxP3+ CD4+ Treg cells and CD8+/CD3+/CD25+/FoxP3+ regulatory CD8+ Treg cells were significantly elevated in all the lung cancer patients before surgery, but not in the RFC group after surgery (Figure 6d). This evidence concerns the gene CD4 and lung cancer.